Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NeuroPace (NPCE) Cash from Financing Activities (2020 - 2025)

Historic Cash from Financing Activities for NeuroPace (NPCE) over the last 6 years, with Q3 2025 value amounting to -$235000.0.

  • NeuroPace's Cash from Financing Activities fell 10810.9% to -$235000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $19.8 million, marking a year-over-year increase of 6944.33%. This contributed to the annual value of $4.3 million for FY2024, which is 4675.77% down from last year.
  • Latest data reveals that NeuroPace reported Cash from Financing Activities of -$235000.0 as of Q3 2025, which was down 10810.9% from -$1.9 million recorded in Q2 2025.
  • NeuroPace's 5-year Cash from Financing Activities high stood at $103.2 million for Q2 2021, and its period low was -$1.9 million during Q2 2025.
  • For the 5-year period, NeuroPace's Cash from Financing Activities averaged around $7.5 million, with its median value being $133500.0 (2023).
  • Its Cash from Financing Activities has fluctuated over the past 5 years, first plummeted by 2560000.0% in 2023, then soared by 2921666.67% in 2025.
  • NeuroPace's Cash from Financing Activities (Quarter) stood at $911000.0 in 2021, then tumbled by 115.15% to -$138000.0 in 2022, then skyrocketed by 6052.17% to $8.2 million in 2023, then crashed by 89.68% to $848000.0 in 2024, then plummeted by 127.71% to -$235000.0 in 2025.
  • Its last three reported values are -$235000.0 in Q3 2025, -$1.9 million for Q2 2025, and $21.1 million during Q1 2025.